Stock Groups

Viatris Earnings Miss, Revenue Beats In Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Viatris Earnings Fall, Revenue Beats Q3

Viatris announced Monday the results of its third quarter. It missed analyst forecasts but generated revenue above expectations.

Viatris reported earnings per share at $0.26 on $4.54B in revenue. Investing.com polled analysts to predict EPS at $0.8834 on revenues of $4.39B.

Viatris shares have fallen 26.73% since the start of the year. However, they are still 27.20% below their 52-week high of $18.86 on December 31, 2020. They are under-performing the S&P 500 which is up 25.07% from the start of the year.

Viatris is following other important earnings from the Healthcare sector this month

Viatris’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Pfizer exceeded expectations by beating all estimates on November 2, with third-quarter EPS at $1.34 on revenues of $24.09B. This compares to the forecast of EPS at $1.08 for revenue of $22.58B.

You can keep up to date on the latest earnings reports at www.investors.com Investing.com’s earnings calendar

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]